Guido Antonelli


Titolo Pubblicato in Anno
Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad IMMUNITY, INFLAMMATION AND DISEASE 2024
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity MICROORGANISMS 2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients MICROORGANISMS 2023
Anti-N SARS-CoV-2 assays for evaluation of natural viral infection JOURNAL OF IMMUNOLOGICAL METHODS 2023
Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients JOURNAL OF MEDICAL VIROLOGY 2023
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients MICROORGANISMS 2023
In Vitro Virucidal Effects of Ultraviolet Light Prototypes on RNA viruses NEW MICROBIOLOGICA 2023
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome JOURNAL OF INFECTION 2023
Editorial: HBV and lymphoma FRONTIERS IN ONCOLOGY 2023
MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression AIDS RESEARCH AND HUMAN RETROVIRUSES 2023
Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy. Broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital ANTIBIOTICS 2023
Interferon-ε as potential inhibitor of Chlamydia trachomatis infection MICROBIAL PATHOGENESIS 2023
Differential expression of type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies IMMUNITY, INFLAMMATION AND DISEASE 2023
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience FRONTIERS IN IMMUNOLOGY 2023
Adherence to SARS-CoV-2 Vaccination Recommendations among Patients with Substance Use Disorders: A Cross-Sectional Study in Rome, Italy VACCINES 2023
Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design JOURNAL OF CLINICAL MEDICINE 2023
Synergistic effect between SARS-CoV-2 wave and COVID-19 vaccination on the occurrence of mild symptoms in healthcare workers VACCINES 2023
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients: a prospective cohort study VACCINES 2022
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma